No abstract available
Keywords:
IL-13; IL-5; cendakimab; dupilumab; eosinophilic esophagitis; mepolizumab.
MeSH terms
-
Biological Therapy
-
Enteritis* / drug therapy
-
Eosinophilia* / drug therapy
-
Eosinophilic Esophagitis* / drug therapy
-
Gastritis* / drug therapy
-
Humans